Updated:
Prometheus Laboratories
Optimizing Your Health Journey with Precision Who We Are We are a specialty clinical laboratory enabling precision-guided care in Inflammatory Bowel Disease...
Prometheus Laboratories
Optimizing Your Health Journey with Precision Who We Are We are a specialty clinical laboratory enabling precision-guided care in Inflammatory Bowel Disease and other GI disorders. We discover, develop and commercialize testing services that help clinicians improve outcomes across the patient journey, from disease interception and stratification, to therapy
General information
Firm type
other
Location
Region
Oceania
Country
United States
City
San Diego
Corporate office
9410 Carroll Park Dr., San Diego, CA 92121, United States
Sector focus
Frequently asked questions
Who runs investment decisions at Prometheus Laboratories?
Prometheus Laboratories has not publicly identified its ownership or executive leadership beyond operational contacts listed on its website. The firm's General Phone Number and client services are managed through its San Diego headquarters. No CEO, CIO, or managing principal is named in public sources.
How does Prometheus Laboratories source proprietary deal flow?
Prometheus Laboratories does not operate as an investment firm; it is a specialty clinical laboratory that develops and commercializes testing services. The company accepts research study proposals via an email address (SMARC@prometheuslabs.com) and education grant requests through mededgrants@prometheuslabs.com, suggesting it engages with external researchers and clinicians for product development.
Is Prometheus Laboratories structured as a single family office or does it operate more like a venture firm?
Prometheus Laboratories does not present itself as a family office or venture firm. Based on publicly available information, it is a clinical laboratory business focused on diagnostic testing for gastrointestinal disorders. Its ownership structure is not disclosed.
Does Prometheus Laboratories participate in fund commitments or only direct deals?
Prometheus Laboratories is not a fund-committing entity. It operates as a clinical laboratory business, generating revenue through testing services. No evidence of fund commitments or direct investment activity exists in public sources.
What investment stages does Prometheus Laboratories typically target?
Prometheus Laboratories does not target investment stages. It is a commercial laboratory that develops and sells diagnostic tests. The company's product pipeline includes tests for disease interception, stratification, therapy selection, and monitoring.
Where does the underlying wealth come from?
Prometheus Laboratories has not disclosed its ownership or the origin of its capital. The company's website lists no founding story, parent entity, or wealth source.
Does Prometheus Laboratories maintain philanthropic structures, and how are they separated?
Prometheus Laboratories offers education grant requests (mededgrants@prometheuslabs.com), but no separate philanthropic foundation or charitable arm is publicly identified.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: